Breakfast – Vistas Dining Room

Registration – Max Bell Central Foyer

10:00 – 11:50 AM

Session 1 – Max Bell Auditorium

Session Chair: Dr. Jolene Garber, University of British Columbia

Keynote 

7 years of human milk oligosaccharide research in the CHILD Cohort: What have we learned and what’s up next?
Dr. Meghan Azad, University of Manitoba

Abstract

A bioengineered plant production system for the anti-diabetes metabolite montbretin A
Dr. Lars Kruse, University of British Columbia 

Abstract

The complexity of O-GlcNAc-mediated regulation of galectin expression and secretion
Dr. Alexander Timoshenko, Western University

Abstract

Glycan binding properties of SARS-CoV-2 receptor binding domain variants of concern
Linh Nguyen, University of Alberta

Abstract

Session 2 – Max Bell Auditorium

Session Chair: Brian Lowrance, Wilfrid Laurier University

Exploring a role for ABO antibodies in the association between ABO blood group and COVID-19 susceptibility
Bushra Anjum, University of Alberta

Abstract

Regulation and targeting of chondroitin sulfate glycosaminoglycans in prostate cancer
Dr. Mads Daugaard, University of British Columbia

Abstract

A “terminal” case of glycan catabolism: structural and enzymatic characterization of the sialidases of Clostridium perfringens
Dr. Kristin Low, Agriculture and Agri-Food Canada

Abstract

Keynote

Rhamnose biosynthesis as an antibacterial target
Dr. David Jakeman 

Abstract

5:45 – 9:00 PM 

6:00 PM

Keynote

The sweet side of sex: Why sex matters in glycobiology
Dr. Cara Tannenbaum 

Session 3 – Max Bell Auditorium

Session Chair: Joshua Kofsky, Queen’s University

Targeted degradation of tumor associated mucins
Gabrielle Tender, Stanford University

Abstract

A novel technique for identifying polysialylated proteins in complex mixtures
Tahlia Derksen, University of Alberta

Abstract

Keynote

Holistic Glycoscience: Combining the power of preclinical models of glycosylation deficiencies with glycomics to interrogate the biologic functions of glycans and their defects in chronic diseases
Dr. Kirk Bergstrom, University of British Columbia Okanagan 

Abstract

Session 4 – Max Bell Auditorium

Session Chair: Ninoschka D’Souza, York University

Keynote

The applications of carbohydrate chemistry to vaccines and adjuvants
Dr. Janelle Sauvageau, National Research Council Canada 

Abstract

Engineering the endothelial glycocalyx using glycopolymer mimics to prevent organ rejection
Haiming Luo, University of British Columbia

Abstract

Identifying glycan consumers in human gut microbiota using metabolic labeling coupled to fluorescence-activated cell sorting
Dr. Bastien Castagner, McGill University

Abstract

Lightning Talks (x3)

Ultrahigh-throughput droplet-based microfluidic screening to discover new efficient enzymes that convert B type red blood cells to universal O type blood
Dr. Charlotte Olagnon, University of British Columbia

Abstract

Development of fluorescence-quenched substrate probes for multiplexed imaging of glycosidase activity within live cells
Dr. Roger Ashmus, Simon Fraser University

Abstract

Shining a light on prebiotic-probiotic fructan-microbial interactions in the rumen
Marissa King, Agriculture & Agri-Food Canada

Abstract

Session 5 – Max Bell Auditorium

Session Chair: Dr. Ifthiha Mohideen, University of Alberta

Lightning Talks (x3)

Between cellulose and chitin, the unique architecture of the chytrid cell wall
David Firer, McGill University

Abstract

Structural and functional characterization of the Clostridioides difficile glycosyl hydrolase CcsZ
Brian Lowrance, Wilfrid Laurier University

Abstract

In situ, O-glycomic, and functional characterization of the gut mucus sialic acid O-acetylome of complex O-glycans derived from human and murine Mucin-2
Simin Jafaripour, University of British Columbia Okanagan

Abstract

Exploring the interaction between mammalian extracellular vesicles and Siglecs
Dr. Dimitra Lamprinaki, University of Alberta

Abstract

Precision labeling and photo-crosslinking of glycoconjugates through cell-surface glyco-engineering
Jonathan Babulic, Queen’s University

Abstract

Keynote

ACE2 and spike glycosylation
Dr. Josef Penninger, University of British Columbia

Abstract

9:00 AM – 12:00 PM

Clinical Partnership Workshop – Max Bell 252

In-person Registration

Virtual Registration

(Free of charge, maximum 50 attendees in person, Symposium attendees welcome to participate) 

• GlycoNet investigators will provide a primer on glycomics (some of the basics) and how GlycoNet can help you get into the details you need to make glycomics work for your research.
• GlycoNet clinician scientists will provide some examples from their work about how they have used glycomics, and how this has changed their research view .
•  Discussion with attendees about problems they are working on and responses from both basic scientists and clinician scientists on potential interactions.